FDA has identified several issues over the past few years related to repackers of bulk drug substances, also called active pharmaceutical ingredients (APIs), used to compound drugs. The agency urges compounders to know your bulks supplier and know if they are testing the drugs before you purchase bu
Similar Posts
Disseminated Coccidioidomycosis: Developing Drugs for Treatment
Disseminated Coccidioidomycosis: Developing Drugs for TreatmentExecutive Order 14017 on America’s Supply Chains
Updates on recommendations to help shore up the U.S. pharmaceutical supply chain, as directed by Executive Order 14017 on America’s Supply ChainsSpring & Mulberry Expands Voluntary Recall of Select Chocolate Bars Due to Possible Salmonella Contamination
Raleigh, North Carolina (January 14, 2026) — Spring & Mulberry is updating their press release previously issued on January 12, 2026, to expand their voluntary recall beyond Mint Leaf to include additional flavors (see table below), due to possible contamination with Salmonella.Aquastar (USA) Corp Recalls Cocktail Shrimp 6oz Because of Possible Health Risk
August 28, 2025, AquaStar (USA) Corp of Seattle, WA is recalling approximately 26,460 packages of Cocktail Shrimp 6oz (see photo), imported from Indonesia, because they may have been prepared, packed, or held under insanitary conditions whereby they may have become contaminated with cesium-137 (Cs-1Post-Warning Letter Meetings Under GDUFA
Post-Warning Letter Meetings Under GDUFAClosed Suction Catheter Recall: Avanos Medical, Inc. Removes Ballard Closed Suction Systems Due to Risk of Non-Sterility
Select Ballard Closed Suction Systems lots may not be sterilized, increasing risk of infection, airway injury, prolonged inflammation, sepsis, or death if used.